awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35048054-89B0AF3C-C9F8-4F08-BADB-D64F0152E7D8
Q35048054-89B0AF3C-C9F8-4F08-BADB-D64F0152E7D8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35048054-89B0AF3C-C9F8-4F08-BADB-D64F0152E7D8
Augmenting antitumor immune responses with epigenetic modifying agents.
P2860
Q35048054-89B0AF3C-C9F8-4F08-BADB-D64F0152E7D8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35048054-89B0AF3C-C9F8-4F08-BADB-D64F0152E7D8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e98a7821d3da716abe2f03d37b2c2c29538fc7dd
P2860
A proof-of-principle study of epigenetic therapy added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer.